Diagnosis and staging of lung cancer;Lungenkarzinom: Diagnostik und staging

Deutsche Medizinische Wochenschrift

Volumn 132, Issue 21, 2007, Pages 1165-1169

  Serke, Monika ^a   Schonfeld N ^a  

^a HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

Author keywords

Bronchoscopy; Computed tomography; Low dose screening CT; Mediastinoscopy; Non small cell lung cancer; Positron emission tomography; Small cell lung cancer; Thoracoscopy; TNM system

Indexed keywords

ALGORITHM; BRONCHOSCOPY; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMMUNOHISTOLOGY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MEDIASTINOSCOPY; PARANEOPLASTIC SYNDROME; POSITRON EMISSION TOMOGRAPHY; REVIEW; SPUTUM CYTODIAGNOSIS; SYMPTOMATOLOGY; THORACOSCOPY; THORAX RADIOGRAPHY;

BIOPSY, FINE-NEEDLE; BONE AND BONES; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PARANEOPLASTIC SYNDROMES; PLEURAL EFFUSION, MALIGNANT; PROGNOSIS; RADIOGRAPHY, THORACIC; RISK FACTORS; SMOKING; THORACOSCOPY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34447310062     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979393     Document Type: Review

References (20)

1. Birim O et al. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in non small cell lung cancer. Ann Thorac Surg 2005; 79: 375-381
2. Bittner RC, Pech M. Staging des Lungenkarzinoms. Pneumologe 2005; 2: 102-110
3. Buccheri G, Ferrigno D. Lung cancer: clinical presentation and specialist referral time. Eur Respir J 2004; 24: 898-904
4. Dietrich CF, Braden B, Wagner TOF. Thorax- und Lungensonographie. Dt Ärztebl 2000; 97: A103-110
5. ESMO. Minimum clinical recommendations for diagnosis, treatment and follow-up of non-small cell lung cancer (NSCLC). Ann Oncol 2005 (S 116: i28-i29
6. Henschke CI et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999; 354: 99-105
7. Herth F, Becker HD. Endoskopische Diagnostik: Bronchoskopie. In Drings P et al. (Hrsg.) Management des Lungenkarzinoms. Springer, Berlin. 2003: 55-60
8. International Union against cancer. TNM classification of malignant tumours, 5 th ed (Hrsg). New York, NY, International Union Against Cancer, 1997
9. Lardinois D, Weder W, Hany TF et al. Staging of non-small cell lung cancer with integrated positron emission tomography and computed tomography. N Engl J Med 2003; 348: 2500-2507
10. Kirby TJ, Stanley CF. Mediastinoscopy. In: Pearson FG, Cooper JD, Deslauries J (eds) Thoracic Surgery, Churchill Livingstone, Philadelphia 2002.
11. Loddenkemper R. Thoracoscopy. Eur Respir J 1998; 11: 213-221
12. Markus A, Hauginger K, Hauck W, Kohlhäufl M. Bronchoskopie in Deutschland: Querschnitterhebung an 681 Institutionen. Pneumologie 2000; 54: 499-507
13. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-1717
14. Nowak D, Ochmann U, Huber RM, Diederich S. Screening des Lungenkarzinoms - aktueller Stand. Pneumologie 2005; 59: 178-191
15. Sobue T, Moriyama N, Kaneko M et al. Screening for lung cancer with low-dose helical computed tomography. J Clin Oncol 2002; 20: 911
16. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer. Summary of published evidence. Chest 2003; 123: 115S-128S
17. Thomas M, Gatzemeier U, Goerg R et al. Empfehlungen zur Diagnostik des Lungenkarzinoms. Pneumologie 2000; 54: 361-371
18. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123: 137-146
19. Travis WD, Brambilla E, Müller-Hermelink HK, Harris C. Pathology and genetics of tumours of the lung, pleura, thymus and heart. World Health Organization classification of tumours.Lyon, France: IARC Press, 2004
20. Vansteenkiste J et al. Positron-emission tomography in prognostic and therapeutic assessment of lung cancer. Lancet Oncol 2004; 5: 531-540